EUCTR2004-001616-31-IT进行中（未招募）不适用
EFFICACY AND SAFETY OF OLMESARTAN IN ELDERLY PATIENTS WITH MILD TO MODERATE HYPERTENSIO
SOFARMACO0 个研究点开始时间: 2004年9月28日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
招募中
4 期
A clinical trail to study the efficacy and safety of low molecular weight heparin (Dalteparin) in elderly Indian patients presenting with acute heart pain patients.CTRI/2010/091/000473Dr.MADDURY JYOTSNA,Associate professor,DEPARTMENT OF CARDIOLOGY,NIMS,PUNJAGUTTA,HYDERABAD,A.P,INDIA-500 082100
招募中
Unknown
The Efficacy and Safety of Imeglimine in Elderly People with Type 2 Diabetes MellitusElderly people with type 2 diabetes (65 years and older)JPRN-UMIN000050556Kitasato University School of Medicine50
招募中
不适用
Efficacy and safety of erlotinib in elderly patients with non-small-cell lung cancer harboring epidermal growth factor receptor mutationsnon-small-cell lung cancerJPRN-UMIN000012056Shimane university hospital38
已完成
不适用
Efficacy and safety of erlotinib in elderly patients with non-small-cell lung cancer without epidermal growth factor receptor mutations: A phase 2 trial.JPRN-UMIN000010526Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine42
已完成
不适用
Efficacy and safety of erlotinib in elderly patients with non-small-cell lung cancer harboring epidermal growth factor receptor mutations: A phase 2 study.non-small-cell lung cancerJPRN-UMIN000010525Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine30